Catalyst Wire Dossier Catalyst Wire Dossier

Elesclomol Sodium

elesclomol · Synta Pharmaceuticals Corp.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Elesclomol Sodium, covering 2009-03-09 to 2014-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer [Phase 1]

See pricing